WikiSWOT.com :: Free CLABSI Prevention SWOT Analysis

User Generated >> CLABSI Prevention SWOT Analysis:

Strengths

Products accessible - CVC insertion kit Arrowgard BLUE, Chloraprep, BioPatch
Current references available - CDC HICPAC, INS, SHEA, IHI
Monitoring already in place (insertion checklist)
Monitoring shows compliance with max barrier precautions
CLABSI already on the Board of Trustees dashboard
Nurse education (orientation and annually) already in place

Weaknesses

Lack of compliance with port disinfection prior to entering IV lines
Doentation is fragmented
Lack of line labeling
Staff are not using BioPatch appropriately (placement)
Lack of proactive effort to remove CVL (attempt PIV prior to dc)

Opportunities

Doentation needs to be standardized (Meditech & McKesson)
- minimize the number of places (screens, interventions) nurses doent
Need accurate doentation of IV tubing and dressing changes
Empower nurses to STOP the LINE if best practices are not met
Need increased attention on removing non-essential tubes (incl. CVL)
Need compliance with Scrub the Hub prior to accessing ports, end caps

Threats

External changes (government, politics, taxes, etc)
Staffing - case mix - nurses may not have time to change dressings, tubings
Standard practice is to leave the line in until discharge
Financial - no reimburt for HAC like CLABSI
Financial - Hub disinfection (Effect-IV for example) additional expense

History: Version 1 (Newest)

Go back to the SWOT analysis index, or start a discussion about CLABSI Prevention SWOT analysis by adding a comment below WikiSWOT Comments

Name
Email (not shared)
Website

Add comment